{"id":371720,"title":"Overview: Guidance document on submission information for biologic drugs (Division 4, Schedule D) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-11","captureTimestamp":"2026-04-11T15:11:31.977000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/submission-information-biologic-drugs-division-4-schedule-d.html","snippet":"Guidance document on submission information for biologic drugs (Division 4, Schedule D): Overview Overview Requirements – Division 4 Requirements – Other References, contacts Comparison of Division 4 – Former and new Download in PDF format (697 KB, 39 pages) Organization: Health…","rawSnapshotUrl":"/api/snapshots/raw/371720","browseUrl":"https://replay.healtharchive.ca/job-6/20260411151131/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/submission-information-biologic-drugs-division-4-schedule-d.html#ha_snapshot=371720","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}